Raymond James Financial Services Advisors’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-8,789
| Closed | -$365K | – | 3281 |
|
|
2023
Q2 | $365K | Sell |
8,789
-3,442
| -28% | -$143K | ﹤0.01% | 2531 |
|
|
2023
Q1 | $736K | Buy |
12,231
+770
| +7% | +$46.3K | ﹤0.01% | 2099 |
|
|
2022
Q4 | $841K | Buy |
11,461
+712
| +7% | +$52.2K | ﹤0.01% | 1947 |
|
|
2022
Q3 | $817K | Sell |
10,749
-139
| -1% | -$10.6K | ﹤0.01% | 1940 |
|
|
2022
Q2 | $757K | Sell |
10,888
-298
| -3% | -$20.7K | ﹤0.01% | 2012 |
|
|
2022
Q1 | $927K | Sell |
11,186
-555
| -5% | -$46K | ﹤0.01% | 2011 |
|
|
2021
Q4 | $882K | Sell |
11,741
-8,632
| -42% | -$648K | ﹤0.01% | 2051 |
|
|
2021
Q3 | $2.37M | Sell |
20,373
-4,078
| -17% | -$474K | ﹤0.01% | 1387 |
|
|
2021
Q2 | $5.42M | Buy |
24,451
+292
| +1% | +$64.8K | 0.01% | 933 |
|
|
2021
Q1 | $3.19M | Sell |
24,159
-1,302
| -5% | -$172K | 0.01% | 1132 |
|
|
2020
Q4 | $4.41M | Sell |
25,461
-90
| -0.4% | -$15.6K | 0.01% | 890 |
|
|
2020
Q3 | $2.84M | Buy |
25,551
+469
| +2% | +$52.2K | 0.01% | 997 |
|
|
2020
Q2 | $1.49M | Sell |
25,082
-7,523
| -23% | -$446K | ﹤0.01% | 1254 |
|
|
2020
Q1 | $2.2M | Sell |
32,605
-1,429
| -4% | -$96.2K | 0.01% | 847 |
|
|
2019
Q4 | $2.87M | Buy |
34,034
+3,290
| +11% | +$277K | 0.01% | 993 |
|
|
2019
Q3 | $2.3M | Buy |
30,744
+11,359
| +59% | +$849K | 0.01% | 1035 |
|
|
2019
Q2 | $1.23M | Buy |
19,385
+127
| +0.7% | +$8.03K | ﹤0.01% | 1387 |
|
|
2019
Q1 | $928K | Sell |
19,258
-1,733
| -8% | -$83.5K | ﹤0.01% | 1503 |
|
|
2018
Q4 | $703K | Buy |
20,991
+513
| +3% | +$17.2K | ﹤0.01% | 1464 |
|
|
2018
Q3 | $1.07M | Buy |
20,478
+11,120
| +119% | +$583K | ﹤0.01% | 1423 |
|
|
2018
Q2 | $293K | Buy |
+9,358
| New | +$293K | ﹤0.01% | 2247 |
|